Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let me tell you a story:
Many years ago GI surgery was done with only hand-sewing to make an anastomosis (connection between 2 segments of intestines). This usually took a long time and there was concern about increased leaks of the anastomosis that lead to increased mortality & morbidity. The hand-sewn connection was only as good as the surgeon's skill and patience. In Russia, someone developed a stapler that could mechanically create an anastomosis. Their was this American guy who was visiting Russia and brought back a sample of this stapler. He met this other guy in the states and together they decided to start a company called US Surgical. They modified the surgical stapler and took 100% of the market-share. It took time for surgeons to except the surgical stapler but. Meanwhile at J&J, a decision was made to try to take part of that market share by selling their own surgical stapler. They hired a guy called John Hargrove for the task. He figured out a way to enable Ethicon to take up 65% of the marked-share in 2 years. US Surgical no longer exists and when you think of surgical staplers today, you think of Ethicon!
...and endovascular interventions.
Questions:
1) Approximately how many additional instruments are being developed? Is a stapler one of them?
2) Could he expand on the additional prototypes? Will they be sequential or separate systems used at different sites?
3) Have they had any contact with Intuitive? Any chance of collaboration to advance robotic surgery faster? Validation?
4) With the increased interest in robotic surgery in residency programs, is their a plan to introduce SPORT to residency programs sooner then later?
Surgibot has the same hand graspers that have been used for over twenty years in laparoscopic surgery. Not ergonomic at all. They obviously didn't perform much human factor analysis. But they are way ahead. Great!
I know but the concept still applies. Several partners of Aisling Capital are Doctors. Others have Health Science degrees. It's about investing in what you understand more than the average investor.
Doctors, engineers and medical device experts aren't very dumb in medical device arena.
Wrong. Aisling Capital has over 8 million shares (largest holdings) of TRXC and they where purchased in 2009, before TRXC went to the NYSE. According to this site:
http://www.aislingcapital.com/portfolio/
SV Life Sciences has over 7 million shares of TRXC and now they own most of Ximedica.
http://www.nasdaq.com/symbol/trxc/ownership-summary
Are the SAB members considered directors and would their purchase of shares be be public information?
Again. It's just a matter of time.
The bovie was more expensive than ties and dangerous. The stapler was more expensive than sutures and not fully tested initially. Lap choles took 2-3 times, or more as long as an open choles for years with an increased rate of complications. It's just a matter of time IMO.
I know they did.
Hiding nothing. He is very motivated and wants to change the landscape of robotic surgery as we know it. He is sincerely sorry for disappointing investors on the 14th but he did what he and his team felt was best for all of us, long term. The challenge is daunting but his resolve is unwavering!
Bottom line, he's a very nice guy and professional and the right person for the job IMO. Please be measured if you must question his daughters salary. He is a family man. We are both Sports Dads and we connected on that level as well.
No Doubt! He even described the video that Duke saw without me even asking about it.
Correct.
Ask him about it tomorrow.
The CEO.
He is meeting with institutional investors during the first 2 weeks of December.
THE BIG PICTURE:
"In the early years of automobile development, a group owned the rights to a two-cycle gasoline engine patent. By controlling this patent, they were able to monopolize the industry and force car manufacturers to adhere to their demands or risk a lawsuit. In 1911, independent automaker Henry Ford won a challenge to the patent. The result was that the patent became virtually worthless and a new association - which would eventually become the Motor Vehicle Manufacturers Association - was formed. The new association instituted a cross-licensing agreement among all U.S. auto manufacturers: although each company would develop technology and file patents, those patents were shared openly and without the exchange of money between all the manufacturers. By the time the U.S. entered WWII, 92 Ford patents and 515 patents from other companies were being shared between these manufacturers, without any exchange of money - or lawsuits. The best braking system was shared by all as was the best window wiper, and many, many other inventions passed freely from one car company to the others. The result was the the user benefitted with the safest and best cars, no matter the brands - and the auto industry flourished as well.
If something like this were to happen in the medical robotics arena, these wonderful new inventions would be available all over the world and patients, care-givers and healthcare systems would all share in the benefits and lives saved."
Excerpt from 2012 article...
"Within the robotics healthcare community, much of that gossip has been focused on Intuitive Surgical and their da Vinci Surgical System. From the beginning, when Intuitive spun out from Stanford and SRI, they immediately had a legal battle with Computer Motion, the inventor of a similar system called Zeus. Since that time Intuitive has regularly contacted competitors to either get them to cease operations or license their patents. Many felt that this thwarted development of competing or better systems than the da Vinci. They have suggested that Intuitive Surgical has made a strategy of amassing large numbers of patents - some of which are so broad as to be susceptible to being thrown out on reexamination - to try to protect their product and market share.
This is the essence of the arguments that people have used against Intuitive Surgical for the past 10 years. Except that no company has asked the Patent Office to reexamine their patents… yet.
In their suit with Computer Motion a decade ago, Intuitive won. But shortly thereafter, Computer Motion won their counter-suit. Stalemate. The two companies met outside of court and agreed to merge, shut down the Zeus operation, pay off the owners of Computer Motion with a small cash amount and 30% of Intuitive Surgical stock - a company that today has a net worth of close to $21 billion. Thus the consequences of these patent battles are significant.
Yulan Wang, the founder of Computer Motion, moved on after the acquisition [of Computer Motion by Intuitive Surgical] to found InTouch Health"
Nice video. Did you know that the company that makes that Remote presence robot (which is FDA approved), In Touch was started by Yulun Wang, their CEO who founded Computer In Motion which was the the first, last and only competitor of Intuitive?
Yes it is. Up state New York. My brother lives there.
You went to school in Ithica?
No. It's the Stifel Conference.
I can't open it. Error
I am of the opinion that she is very qualified. She could have probably made more elsewhere and stayed closer to home in Atlanta with her young kids without the extent of travel. She's doing this for Dad and not the other way around. IMO.
Correct
Hopefully JH learns from those mistakes. Did you notice that they are claiming to capture only 2 million cases vs 4 million? What really bothered me was no reference to a single well known MIS surgeon as seen on their website. Bottom line...don't do presentations until you have all your ducks in a row and quote or bring along some well known surgeons. IMO.
Their CEO presented at Stifel and showed a video of surgibot. They almost all their instrumentation is ready to go. All the crowd cared about was the delay, the COO "and what about ISRGs SP?" Something stinks!
Yes you did mention that number of shares but the language and verbiage of the "hacker" was dead on you.
.....and he is meeting with institutional investors over the next few weeks.
Ay Yi Yi Yi!
Yes, great 2 days. I still can't look at the accounts yet though. But the nausea is gone.
It's the first time he's been suspended.
No need for those ridiculous billboards!
How is he an administrator?
Nice find! What do you get when gather some of the top MIS experts in the country and ask them; How do you suggest we make a good surgical robot?....The upcoming SPORT.
They are the scavengers of the stock market fighting for the scraps, bottom of the food chain. Unworthy of being in the Wolf Pack going for the big kill.
Fact: There are NO day traders featured in the Fortune 500 magazines just smart investors.